Patents by Inventor Dana Ann KENNEDY

Dana Ann KENNEDY has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Combination of Talazoparib and an Anti-Androgen for the Treatment of DDR Gene Mutated Metastatic Castration-Sensitive Prostate Cancer
    Publication number: 20240180906
    Abstract: This invention relates to combination therapies comprising talazoparib, or a pharmaceutically acceptable salt thereof, and an anti-androgen, or a pharmaceutically acceptable salt thereof, and associated pharmaceutical compositions, methods of treatment, and pharmaceutical uses for the treatment of metastatic castration-sensitive prostate cancer in subjects identified as having at least one DNA damage repair gene mutation.
    Type: Application
    Filed: March 21, 2022
    Publication date: June 6, 2024
    Applicants: Pfizer Inc., Astellas Pharma Inc.
    Inventors: Akos Gabor Czibere, Dana Ann Kennedy
  • METHODS FOR TREATING CANCERS WITH ANTIBODY DRUG CONJUGATES (ADC) THAT BIND TO 191P4D12 PROTEINS
    Publication number: 20230364254
    Abstract: Provided herein are methods for treating cancers with antibody drug conjugates (ADC) that bind to 191P4DI2 protein (Nectin-4).
    Type: Application
    Filed: October 8, 2021
    Publication date: November 16, 2023
    Applicants: AGENSYS, INC., SEAGEN INC.
    Inventors: Elaina Marie GARTNER, Eric John CHOWN, Tina KIM-HAFKEN, Dana Ann KENNEDY